KRT19 and hepatocellular carcinoma: For example, Yang and colleagues revealed that CK19-positive HCC possessed an inhibitory TAM niche and identifies, for the first time, a significant enrichment of specific SPP1-positive TAMs in CK19-positive HCC (52).